SELENBP1 is identified as one of the candidate stromal epithelial cross-talk genes by analyzing common single-nucleotide polymorphisms (SNPs) for their association between the risk of serous ovarian cancer and telomerase reverse transcriptase (TERT), a cancer susceptibility “hot-spot” (Johnatty et al., 2010). This evidence concerns the gene SELENBP1 and cancer.